The role of menin in parathyroid tumorigenesis

Advances in Experimental Medicine and Biology

Volumn 668, Issue , 2009, Pages 79-86

  Agha, Amar ^a   Davenport, Colin ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PARATHYROID HORMONE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; MEN1 PROTEIN, HUMAN; ONCOPROTEIN; SMAD PROTEIN;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY LOSS; HORMONAL REGULATION; HUMAN; HYPERPARATHYROIDISM; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PARATHYROID CELL; PARATHYROID TUMOR; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; GENETICS; METABOLISM; MUTATION; PARATHYROID GLAND; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIMARY HYPERPARATHYROIDISM; REVIEW;

HUMANS; HYPERPARATHYROIDISM, PRIMARY; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77950344461     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (26)

1. Bilezikian JP, Silverberg SJ. Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med 2004; 350:1746-175.I. (Pubitemid 38501143)
2. Yao K, Singer FR, Roth SI et al. Weight of normal parathyroid glands in patients with parathyroid adenomas. J Clin Endocrinol Metab 2004; 89:3208-3213. (Pubitemid 38951885)
3. Imanishi Y,Hosokawa Y,Yoshimoto K et al. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Investig 2001: 107:1093-102. (Pubitemid 32422906)
4. Costa-Guda J. Tokura T, Roth SIet al. Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas. BMC Endocr Disord 2007: 7:8.
5. Dotzenrach C, Teh BT, Farnebo Fet al. Allelic loss of the retinoblastoma tumor suppressor gene: A marker for aggressiveparathyroid tumors? J Clin Endocrinol Merab 1996: 81:3194-6. (Pubitemid 26296187)
6. Larsson C, Skogseid B, Oberg Ket al. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature (Lond) 1988: 332:85-7. (Pubitemid 18083554)
7. Brandi ML, Gagel RF, Angeli Aet al. Guidelines for diagnosis and therapy of MEN type 1 and type 2.J Clin Endocrinol Metab 2001: 86:5658-7.I. (Pubitemid 33152604)
8. Heppner C, Kester MB, Agarwal SKet al. Somatic mutation of the MEN1 gene in parathyroid tumors,Nat Genet 1997: 16:375-8. (Pubitemid 27323304)
9. Farnebo F, Teh B, Kytola Set al. Alterations of the MENI gene in sporadic parathyroid rumors.J Clin Endocrinol Metab 1998: 83:2627-30, (Pubitemid 28493751)
10. Sowa H, Kaji H, Kitazawa Ret al. Menin inactivation leads to loss of transforming growth factor e inhibition of parathyroid cell proliferation and parathyroid hormone secretion. Cancer Res 2004: 64(6) :2222-8. (Pubitemid 38339476)
11. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MENl): Analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Murat 2008: 29:22-32.
12. Naito J, Kaji H, Sowa Het al. Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN 1) patient with somatic loss of heterozygosity in chromosome l1q13 and unidentified germline mutation of the MEN1 gene. Endocrine 2006: 29:485-90. (Pubitemid 44358839)
13. Bhuiyan MM, Saro M, Murao Ket al. Expression of menin in parathyroid tumors. J Clin Endocrinol Metab 2000: 85:2615-9. (Pubitemid 32269223)
14. Ross S, Hill CS. How the Smads regulate transcription, IntJ Biochem Cell Bioi 2008: 40:383-408 (Pubitemid 351241229)
15. Kaji H, CanaffL, LebrunJJet al. Inactivation of menin, a Smad3-interacting protein, blocks transforming growch factor type e signalling. Proc Natl Acad Sci USA 2001: 98:3837-42, (Pubitemid 32249858)
16. Shattuck TM, CostaJ, Bernstein Met al. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-e and menin pathways, in parathyroid adenomas and enteropancre atic endocrine tumors.J Clin Endocrinol Metab 2002: 87:3911-4. (Pubitemid 34879547)
17. Subramaniam N, Leong GM, Cock TA et al. Cross-talk between 1,25-dihydtOxyvitamin D3 and transforming growth factor-B signalling requires binding ofVDR and Smad3 proteins to their cognate DNA recognition elemenrs.J Bioi Chern 2001: 276:15741-6.
18. Kremer R, Bolivar 1, Goltzman Det al. Influence of calcium and 1,25-dihydtOxycholecalciferol on ptOliferation and ptoto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinolog y 1989: 125:935-4.I. (Pubitemid 19205090)
19. Arnold A, Brown MF, Urena Pet al. Monoclonal ity of parathyroid tumors in chronic renal failure and in primar y parathyroid hyperplasia. J Clin Investig 1995: 95:2047-53.
20. Malachi TD, Zevi U, Gafier A et al. DNA repair and recovery of RNA synthesis in uremic patients,Kidney Int 1993: 44:385-389.
21. Shan L, Nakamura Y, Murakami Met al. Clonal emergence in uremic parathyroid hyperplasia is not related to MEN1 gene abnormality Jpn. J Cancer Res 1999: 90:965-9. (Pubitemid 29500435)
22. Tahara H, Imanishi Y, Yamada Tet al. Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia. J Clin Endocrinol Metab 2000: 85:4113-7. (Pubitemid 32055361)
23. Imanishi Y, Tahara H, Palanisamy Net al. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism in uremia. J Am Soc Nephrol 2002: 13:1490-8. (Pubitemid 34579238)
24. Haven CJ, van Puijenbroek M, Tan MHet al. Identification ofMEN 1 and HRPT2 somatic mutat ions in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol (Oxf) 2007: 67:370-6. (Pubitemid 47283832)
25. Agha A, Carpenter R, Bhattacharya Set al. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MENl) syndrome: Two case reports of an unrecognised entity. J EndocrinolInvest 2007: 30:145-9. (Pubitemid 46614446)
26. Dionisi S, Minisola S, Pepe Jet al. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: Presentation as hypercalcemic crisis. Mayo Clin Proc 2002: 77:866-9. (Pubitemid 34847726)